Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

Overview of attention for article published in BMC Cancer, May 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,781 followers.

◈ Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correl... http://t.co/7KEzSM774E ◈

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a corr... http://t.co/qpKwOWgZKc #cancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.